Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Nature|April 16, 1981
A cyanine dye distinguishes between cycling and non-cycling fibroblastsR L Cohen, K A Muirhead, J E Gill, et al.American Journal of Infection Control|August 1, 1985
Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary cathetersD K Steward, G L Wood, R L Cohen, et al.The Journal of Biological Chemistry|July 21, 1995
Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptorA Higazi, R L Cohen, J Henkin, et al.The Journal of Investigative Dermatology|January 1, 1984
Direct effects of minoxidil on epidermal cells in cultureR L Cohen, M E Alves, V C Weiss, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1983
Biofeedback and relaxation in the treatment of migraine headaches: comparative effectiveness and physiological correlatesJ M Lacroix, M A Clarke, J C Bock, et al.Archives of Disease in Childhood|October 1, 1993
Occurrence of Duchenne dystrophy in Klinefelter's syndromeV Ramesh, R Mountford, H M Kingston, et al.Health Affairs (Project Hope)|August 10, 2016
Delivering On Accountable Care: Lessons From A Behavioral Health Program To Improve Access And OutcomesRobin M A Clarke, Jessica Jeffrey, Mark Grossman, et al.Cancer Immunology, Immunotherapy : CII|February 1, 1995
Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytomaJ M Cook-Mills, M B Mokyr, R L Cohen, et al.International Journal of Cancer|March 3, 1995
Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancerE Bianchi, R L Cohen, A Dai, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 8, 2009
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapyKristen M Marks, Robin M A Clarke, James B Bussel, et al.Pageof 11